Novacyt S.A. (AIM:NCYT)
39.50
+1.25 (3.27%)
May 9, 2025, 4:35 PM GMT+1
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
Yourgene Health | 6.48M |
Log In |
Log In |
Log In |
Log In |
Primer Design | 5.73M |
Log In |
Log In |
Log In |
Log In |
Primer Design Growth | -75.08% |
Log In |
Log In |
Log In |
Log In |
IT-IS International | 1.10M |
Log In |
Log In |
Log In |
Log In |
IT-IS International Growth | -33.75% |
Log In |
Log In |
Log In |
Log In |
Intercompany Eliminations | - |
Log In |
Log In |
Log In |
Log In |
Intercompany Eliminations Growth | - |
Log In |
Log In |
Log In |
Log In |
Lab21 Products | - |
Log In |
Log In |
Log In |
Log In |
Lab21 Products Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
---|---|---|---|---|---|
United Kingdom | 3.87M |
Log In |
Log In |
Log In |
Log In |
United Kingdom Growth | -67.41% |
Log In |
Log In |
Log In |
Log In |
Asia-Pacific | 3.18M |
Log In |
Log In |
Log In |
Log In |
Asia-Pacific Growth | 46.62% |
Log In |
Log In |
Log In |
Log In |
Europe (Excluding United Kingdom and France) | 2.12M |
Log In |
Log In |
Log In |
Log In |
Europe (Excluding United Kingdom and France) Growth | -53.10% |
Log In |
Log In |
Log In |
Log In |
America | 1.91M |
Log In |
Log In |
Log In |
Log In |
America Growth | -63.70% |
Log In |
Log In |
Log In |
Log In |
France | 1.22M |
Log In |
Log In |
Log In |
Log In |
Africa | 515.10K |
Log In |
Log In |
Log In |
Log In |
Africa Growth | 22.76% |
Log In |
Log In |
Log In |
Log In |
Middle East | 509.36K |
Log In |
Log In |
Log In |
Log In |
Middle East Growth | 15.28% |
Log In |
Log In |
Log In |
Log In |